Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

13.74
EUR
+0.26
(+1.93%)
0.12EPS
130.48P/E
1.73BMarket Cap
Mar 03Next Earn

Sarepta Therapeutics, Inc. Documents

Q2 FY2022 · Presentation

Sarepta Therapeutics Inc - Q2 2022 - Conference Call Deck · 1 page

Read Sarepta Therapeutics, Inc.'s results firsthand

Preview this presentation
Create a free account to start reading

Full documents are included with Professional

Q2 FY2022 documents